enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.51
+0.01 (0.13%)
Nov 21, 2024, 1:12 PM EST - Market open

enGene Holdings Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jul '24 Oct '23 Oct '22 Oct '21 Oct '20
Selling, General & Admin
22.579.63.963.413.24
Research & Development
32.7116.4615.4712.4610.61
Operating Expenses
55.2826.0619.4315.8713.85
Operating Income
-55.28-26.06-19.43-15.87-13.85
Interest Expense
-3.2-4.95-1.42-5.02-3.7
Interest & Investment Income
7.81.120.130.030.06
Currency Exchange Gain (Loss)
0.41-0.1-0.7-0.1-0.1
Other Non Operating Income (Expenses)
-15.35-10.6-3.02-4.20.97
EBT Excluding Unusual Items
-65.63-40.6-24.44-25.17-16.63
Other Unusual Items
-56.73-59.3-1.731.56
Pretax Income
-122.36-99.9-24.44-23.44-15.07
Income Tax Expense
-0.020.020.02--
Net Income
-122.34-99.92-24.46-23.44-15.07
Preferred Dividends & Other Adjustments
1.14.824.56-1.191.58
Net Income to Common
-123.44-104.74-29.02-22.25-16.65
Shares Outstanding (Basic)
271143
Shares Outstanding (Diluted)
271143
Shares Change (YoY)
590.98%5.72%-81.61%28.93%-
EPS (Basic)
-4.60-151.22-44.30-6.25-6.02
EPS (Diluted)
-4.60-151.22-44.30-6.25-6.02
Free Cash Flow
-36.31-25.06-17.75-16.23-13.25
Free Cash Flow Per Share
-1.35-36.18-27.09-4.56-4.80
EBITDA
-55-25.89-19.19-15.6-13.59
D&A For EBITDA
0.290.180.240.270.26
EBIT
-55.28-26.06-19.43-15.87-13.85
Source: S&P Capital IQ. Standard template. Financial Sources.